Mineralizing Enthesopathy Is a Common Feature of Renal Phosphate-Wasting Disorders Attributed to FGF23 and Is Exacerbated by Standard Therapy in Hyp Mice

por Karaplis, Andrew C., Bai, Xiuying, Falet, Jean-Pierre, Macica, Carolyn M.
Publicado em 2012

CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders

por Bai, Xiuying, Miao, Dengshun, Xiao, Sophia, Qiu, Dinghong, St-Arnaud, René, Petkovich, Martin, Gupta, Ajay, Goltzman, David, Karaplis, Andrew C.
Publicado no J Clin Invest (2016)